Remove Article Remove Bioinformatics Remove Small Molecule
article thumbnail

AI in Drug Discovery - A Highly Opinionated Literature Review (Part III)

Practical Cheminformatics

Following up on Part I and Part II, the third post in this series is a collection of review articles published in 2023 that I found helpful.

article thumbnail

Reaching cruising altitude: New discovery tools to target RNA

Dark Matter Blog

The majority of small molecule drugs induce their therapeutic effects by seeking out and binding to their intended target while avoiding most other molecules in the dense milieu of the cell interior. Our overall mission at Arrakis is to expand the set of “druggable” targets for small-molecule medicines to include RNA.

RNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

Drugs that were developed and commercialised 30+ years ago were relatively simple small molecules. Todays small molecules are far larger, more complex, and chase highly specific (and difficult to hit) targets, thereby increasing the chances of undesired side effects. This failure is getting more pronounced by the day.

article thumbnail

Codon Digest: GPT-4 Controls a Robot

Codon

BMC Bioinformatics. Read There’s a news article that breaks down this work. Read Retracted Covid-19 articles: significantly more cited than other articles within their journal of origin. Read Deep learning of genomic contexts predicts protein co-regulation and function. McCafferty C.L. Favate J.S. Debès C.